Clinical Trials Logo

Cerebellar Diseases clinical trials

View clinical trials related to Cerebellar Diseases.

Filter by:

NCT ID: NCT05024240 Active, not recruiting - Cerebellar Ataxia Clinical Trials

Interaction of the Cognitive and Sensory-cognitive Tasks With Postural Stability in Individuals With Stability Disorders

Start date: October 10, 2018
Phase: N/A
Study type: Interventional

The aim of this study is to describe the interaction of the cognitive and visual-cognitive task with postural stability in patients suffering by cerebellar ataxia. Investigators will measure changes in postural stability parameters and in secondary task performance, which should show the ability of the patients to manage the dualtask situations.

NCT ID: NCT05002218 Active, not recruiting - Cerebellar Ataxia Clinical Trials

Training in Ataxia - Individuals With Degenerative Cerebellar Diseases

Start date: January 31, 2022
Phase: N/A
Study type: Interventional

Balance and aerobic training show promise as treatments for degenerative cerebellar diseases, but the neural effects of both training methods are unknown. The goal of this project is to evaluate how each training method impacts the brain, and particularly, the degenerating cerebellum. Various neuroimaging techniques will be used to accomplish this goal and test the hypothesis that balance training impacts brain structures outside the cerebellum whereas aerobic training causes more neuroplastic changes within the cerebellum.

NCT ID: NCT03769961 Terminated - Essential Tremor Clinical Trials

Ataxia in Essential Tremor: Describing the Differences Between Disease Process and Treatment Effect

ATAX
Start date: December 1, 2018
Phase:
Study type: Observational

The proposed study aims to characterize ataxia occurring in essential tremor and essential tremor with DBS.

NCT ID: NCT03745248 Completed - Ataxia Clinical Trials

Aerobic Exercise, Balance Training, and Ataxia

Start date: November 14, 2018
Phase: N/A
Study type: Interventional

The first aim is to show aerobic training improves degenerative cerebellar patients functionally The second aim is to compare the effects of balance and aerobic training on degenerative cerebellar disease.

NCT ID: NCT03662737 Completed - Healthy Clinical Trials

VRT as a Biomarker of Cerebellar Dysfunction in Chronic Cannabis Use

Start date: September 1, 2019
Phase:
Study type: Observational

Chronic cannabis consumption has been associated with poor psychosocial functioning that could be associated to cerebellar dysfunction. The cerebellum has a relevant role in adaptation processes and has a high density of cannabinoid 1 receptor (CB1R). Implicit motor learning is a cerebellum dependent function that can be measured with a visuomotor rotation task (VRT). The project aims to identify a sensitive and specific biomarker of cerebellum dysfunction in chronic cannabis users. The investigators would like to demonstrate that the visuomotor rotation paradigm is valid to measure and quantify such a dysfunction. A longitudinal prospective study with a 3 month follow-up is proposed. 3 groups will be included: 1) chronic cannabis users; 2) individuals with an alcohol use disorder; and 3) healthy controls. All groups will be matched by sex and age. Forty individuals will be included in each group. Individuals will be assessed at baseline, at first month and at 3-months of follow-up. Sociodemographic and clinical data will be recorded. Information on cannabis consumption will be registered using an App. Participants will do the visuomotor rotation task and answer three questionnaires: the Intrinsic Motivation Inventory, the Scale for the assessment and rating of ataxia (SARA) and the Harris tests for lateral dominance. The biomarker developed by this project will facilitate the detection of cerebellar alterations in chronic cannabis users, and will permit to quantify and monitor such alteration over time. The team's intention is to patent the proposed model and disseminate it in order to use it in clinical practice at both primary and specialized health centres.

NCT ID: NCT03112408 Completed - Cerebellum Disease Clinical Trials

Eye Movements and Visuo-spatial Perception

Start date: September 26, 2018
Phase: N/A
Study type: Interventional

This research aims to highlight the key roles of the cerebellar and cortical fronto-parietal networks in the coupling of eye movements with visual perception and visuo-spatial attention.

NCT ID: NCT02106819 Completed - Cerebellar Diseases Clinical Trials

Emotional Communication Disorders in Cerebellar Disease

Start date: April 2014
Phase: N/A
Study type: Observational

The cerebellum has been linked to cognitive and emotional functions and there is increasing evidence that damage to posterior portions of the cerebellum can result in frontal-executive, visuospatial, and verbal deficits, including dysprosodia, and affective changes including blunting of affect or disinhibited and inappropriate behavior. Based on preliminary clinical observations and tests performed in the investigator's clinic, disorders of emotional communication may also be associated with cerebellar dysfunction. Emotional communication includes the production and comprehension of facial and prosodic expressions and is critical to maintaining positive and supportive relationships. Deficits in emotional communication can have devastating effects on relationships and on quality of life for those affected. Although deficits in affect and prosody have been reported in association with posterior cerebellar disorders, there are currently no studies systematically investigating emotional communication in individuals with cerebellar dysfunction. It is known that the cerebellum has strong connections with the cerebral cortex, especially the frontal lobes, and that cortical damage from stroke or neurodegenerative disease can result in disorders of emotional communication. Impairments in the integrity of cerebellar-cerebral networks from cerebellar disease may produce similar deficits in emotional communication. The purpose of this study is to systematically investigate and describe deficits in emotional communication in a series of patients with cerebellar disease. Participants will be individuals diagnosed with posterior cerebellar degeneration or damage from a non-hemorrhagic infarction, and age-matched neurologically healthy controls. Assessment will include a battery of tests of neuropsychological function as well as tests of emotional communication. Comprehension of emotional facial and prosodic expressions will be assessed as well as production of emotional communication. The expected outcomes will be to identify and describe deficits in production and comprehension of emotional prosodic and facial expressions and to describe the relationship between deficits in emotional communication and cerebellar atrophy with magnetic resonance imaging imaging (MRI) using voxel based morphometry (VBM).

NCT ID: NCT00873678 Completed - Joubert Syndrome Clinical Trials

Assessment of the Prevalence of Genes AHI1, NPHP1 and CEP290 in Joubert Syndrome

JSCORS
Start date: March 2007
Phase: N/A
Study type: Observational

Primary objective: - assessment of the prevalence of AHI1 mutations in Joubert syndrome and cerebello-oculo-renal syndromes (JS/CORS) Secondary objective: - assessment of the prevalence of CEP290 mutations and NPHP1 homozygous deletions in JS/CORS - caracterization of mutational spectrum of AHI1, NPHP1, CEP290 genes in JS/CORS. - evaluation of genotype-phenotype correlation in JS/CORS.

NCT ID: NCT00487383 Terminated - Dystonia Clinical Trials

Brain Changes in Blepharospasm

Start date: June 12, 2007
Phase:
Study type: Observational

This study will examine the role of certain areas of the brain in blepharospasm, a type of dystonia (abnormality of movement and muscle tone) that causes unwanted or uncontrollable blinking or closing of the eyelids. The study will compare brain activity in healthy volunteers and in people with blepharospasm to find differences in the brain that may lead to better treatments for dystonia. Healthy volunteers and people with blepharospasm who are 18 years of age and older may be eligible for this study. All candidates are screened with a medical history. People with blepharospasm also have a physical examination and blepharospasm rating. Participants undergo transcranial magnetic stimulation (TMS) and electromyography (EMG) in two 4-hour sessions, separated by 1 to 7 days. TMS A wire coil is held on the subject s scalp. A brief electrical current is passed through the coil, creating a magnetic pulse that stimulates the brain. The subject hears a click and may feel a pulling sensation on the skin under the coil. There may be a twitch in muscles of the face, arm or leg. During the stimulation, subjects may be asked to tense certain muscles slightly or perform other simple actions. Repetitive TMS involves repeated magnetic pulses delivered in short bursts of impulses. Subjects receive 60 pulses per minute over 15 minutes. EMG Surface EMG is done during TMS to measure the electrical activity of muscles. For this test, electrodes (small metal disks) are filled with a conductive gel and taped to the skin of the face.

NCT ID: NCT00266760 Completed - Cerebellar Diseases Clinical Trials

Characteristics of Episodic Ataxia Syndrome

Start date: May 2006
Phase:
Study type: Observational

Episodic ataxia (EA) is a rare genetic disease characterized by episodes of imbalance, incoordination, and slurring of speech. The underlying cause of EA is only partly understood, and currently there are no established treatments. There is also little information about the link between EA's clinical features and its genetic basis. The purpose of this study is to better characterize EA and disease progression. In turn, this may direct the development of future treatments.